Table 1.
Demographics of the Patients and Their Cancers.
| Characteristic |
CT-PFNECII + Chemotherapy |
% |
Chemotherapy |
% |
|---|---|---|---|---|
| (n = 17) |
(n = 17) |
|||
| No. of Patients | No. of Patients | |||
| Age, yr | ||||
| Median | 55 | 57 | ||
| Range | 32-74 | 35-76 | ||
| Male sex | 13 | 12 | ||
| Weight, kg | ||||
| Median | 65 | 64 | ||
| Range | 41-105 | 38-94 | ||
| Interval from last chemotherapy to inclusion, months | ||||
| Median | 2.5 | 2.5 | ||
| Interquartile range | 2-9 | 2-10 | ||
| Patients with tumor-related chest pain or dyspnea | 7 | 6 | ||
| Times of CT-PFNECII | ||||
| 4 | 7 | 41.18 | ||
| 2 | 10 | 58.82 | ||
| ECOG status⁎ | ||||
| ≤ 1 | 5 | 29.41 | 5 | 29.41 |
| 2 | 12 | 70.59 | 12 | 70.59 |
| Cancer stage | ||||
| IV | 17 | 100 | 17 | 100 |
| Histologic type of cancer | ||||
| Adenocarcinoma | 8 | 47.06 | 8 | 47.06 |
| Squamous | 5 | 29.41 | 7 | 41.18 |
| Sarcomatoid carcinoma | 1 | 5.88 | 0 | 0 |
| Large cell | 0 | 0 | 0 | 0 |
| Other | 3 | 17.65 | 2 | 11.77 |
| Tumor size, cm | ||||
| 3-5 | 11 | 10 | 58.82 | |
| > 5 | 6 | 7 | 41.18 | |
| Platinum-resistant patients | 5 | 5 | 29.41 | |
⁎
Higher scores on the ECOG scale indicate poorer performance.